EUROCAT study on maternal diabetes

Maternal diabetes is a known risk factor for congenital malformations (CM). It has also been known for many years that good metabolic control in the preconceptional period decreases the risk of CM. Maternal hyperglycemia is a non-specific teratogen imposing the same risk of CM to pregnant women with both type-1 and type-2 diabetes.  

Aims of EUROCAT Diabetes Study: To describe the distribution of types of CM in diabetic pregnancies and compare with the distribution of CM in pregnancies without maternal disease before pregnancy in the same populations. To describe severity of CM and birth outcome (livebirth, fetal death, TOP, perinatal mortality) in diabetic pregnancies and compare with pregnancies without maternal diseases before pregnancy in the same populations.